CIK 0001699031 · Non-accelerated filer<br>Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863673636
- Phone
- (833) 694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- 4 Grant or award Director acquired 425 shares (grant or award)
- 4 Grant or award Director acquired 275 shares (grant or award)
- 8-K Event Material agreement · Results of operations · Unregistered share sale · Regulation FD disclosure
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale President sold 81,385 shares at $62.50 ($5,086,563)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale President sold 9,692 shares at $64.00 ($620,312)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Material agreement · New debt or obligation
- 4 Open-market sale President sold 4,202 shares at $32.02 ($134,548)
- 4 Open-market sale Chief Financial Officer sold 877 shares at $32.02 ($28,082)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 6 of 14 · 267 filings